Cargando…

Revisiting the Role of Astrocytic MAOB in Parkinson’s Disease

Monoamine oxidase-B (MAOB) has been believed to mediate the degradation of monoamine neurotransmitters such as dopamine. However, this traditional belief has been challenged by demonstrating that it is not MAOB but MAOA which mediates dopamine degradation. Instead, MAOB mediates the aberrant synthes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nam, Min-Ho, Sa, Moonsun, Ju, Yeon Ha, Park, Mingu Gordon, Lee, C. Justin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028367/ https://www.ncbi.nlm.nih.gov/pubmed/35457272 http://dx.doi.org/10.3390/ijms23084453

Ejemplares similares

The Pathological Role of Astrocytic MAOB in Parkinsonism Revealed by Genetic Ablation and Over-expression of MAOB
por: An, Heeyoung, et al.
Publicado: (2021)

Generation of Astrocyte-Specific MAOB Conditional Knockout Mouse with Minimal Tonic GABA Inhibition
por: Lee, Jung Moo, et al.
Publicado: (2022)

Role of Hypothalamic Reactive Astrocytes in Diet-Induced Obesity
por: Sa, Moonsun, et al.
Publicado: (2022)

Functional MAOB Gene Intron 13 Polymorphism Predicts Dyskinesia in Parkinson's Disease
por: Löhle, Matthias, et al.
Publicado: (2022)

Differential Proximity of Perisynaptic Astrocytic Best1 at the Excitatory and Inhibitory Tripartite Synapses in APP/PS1 and MAOB-KO Mice Revealed by Lattice Structured Illumination Microscopy
por: An, Heeyoung, et al.
Publicado: (2021)

The relationship between monoamine oxidase B (MAOB) A644G polymorphism and Parkinson disease risk: a meta-analysis
por: Liu, Ying, et al.
Publicado: (2014)

Unaltered Tonic Inhibition in the Arcuate Nucleus of Diet-induced Obese Mice
por: Sa, Moonsun, et al.
Publicado: (2022)

MAOB rs3027452 Modifies Mood Improvement After Tryptophan Supplementation
por: Gonzalez, Irene, et al.
Publicado: (2021)

Relationships of Cerebrospinal Fluid Alzheimer’s Disease Biomarkers and COMT, DBH, and MAOB Single Nucleotide Polymorphisms
por: Babić Leko, Mirjana, et al.
Publicado: (2020)

Orai1 and Orai3 in Combination with Stim1 Mediate the Majority of Store-operated Calcium Entry in Astrocytes
por: Kwon, Jea, et al.
Publicado: (2017)

Dopamine-induced astrocytic Ca(2+) signaling in mPFC is mediated by MAO-B in young mice, but by dopamine receptors in adult mice
por: Kim, Sunpil, et al.
Publicado: (2022)

Fatty Acid Increases cAMP-dependent Lactate and MAO-B-dependent GABA Production in Mouse Astrocytes by Activating a G(αs) Protein-coupled Receptor
por: Lee, NaHye, et al.
Publicado: (2018)

The Association between a MAOB Variable Number Tandem Repeat Polymorphism and Cocaine and Opiate Addictions in Polyconsumers
por: Mateu, César, et al.
Publicado: (2021)

Inhibition of MAOB Ameliorated High-Fat-Diet-Induced Atherosclerosis by Inhibiting Endothelial Dysfunction and Modulating Gut Microbiota
por: Tian, Zhen, et al.
Publicado: (2023)

Astrocytes, Microglia, and Parkinson's Disease
por: Joe, Eun-Hye, et al.
Publicado: (2018)

Role of Paeonol in an Astrocyte Model of Parkinson’s Disease
por: Ye, Maosheng, et al.
Publicado: (2017)

The Role of Astrocyte Dysfunction in Parkinson’s Disease Pathogenesis
por: Booth, Heather D.E., et al.
Publicado: (2017)

The Potential Role of Astrocytes in Parkinson’s Disease (PD)
por: Hindeya Gebreyesus, Hiluf, et al.
Publicado: (2020)

Astrocytic Oxidative/Nitrosative Stress Contributes to Parkinson’s Disease Pathogenesis: The Dual Role of Reactive Astrocytes
por: Rizor, Asha, et al.
Publicado: (2019)

Role of Astrocytes in Parkinson’s Disease Associated with Genetic Mutations and Neurotoxicants
por: Kim, Sanghoon, et al.
Publicado: (2023)

Retracted: Role of Paeonol in an Astrocyte Model of Parkinson Disease
por: Ye, Maosheng, et al.
Publicado: (2021)

Mitochondrial Dysfunction in Astrocytes: A Role in Parkinson’s Disease?
por: Bantle, Collin M., et al.
Publicado: (2021)

Astrocytes in Parkinson’s Disease: From Role to Possible Intervention
por: Wang, Tianyou, et al.
Publicado: (2023)

Activation of Astrocytic μ-opioid Receptor Elicits Fast Glutamate Release Through TREK-1-Containing K2P Channel in Hippocampal Astrocytes
por: Woo, Dong Ho, et al.
Publicado: (2018)

Hepatic CYP3A4 Enzyme Compensatively Maintains Endogenous Geranylgeranoic Acid Levels in MAOB-Knockout Human Hepatoma Cells
por: Tabata, Yuki, et al.
Publicado: (2022)

Drug and Disease Effects in Parkinson's Psychosis: Revisiting the Role of Dopamine
por: Dave, Sonali, et al.
Publicado: (2019)

Emerging Roles for Aberrant Astrocytic Calcium Signals in Parkinson’s Disease
por: Bancroft, Eric A., et al.
Publicado: (2022)

High-yield synthesis and purification of recombinant human GABA transaminase for high-throughput screening assays
por: Park, Mingu Gordon, et al.
Publicado: (2021)

Metabolic alterations in Parkinson’s disease astrocytes
por: Sonninen, Tuuli-Maria, et al.
Publicado: (2020)

Neuron-Astrocyte Interactions in Parkinson’s Disease
por: Miyazaki, Ikuko, et al.
Publicado: (2020)

Therapeutic functions of astrocytes to treat α-synuclein pathology in Parkinson’s disease
por: Yang, Yunseon, et al.
Publicado: (2022)

Exosomes in Parkinson: Revisiting Their Pathologic Role and Potential Applications
por: Ouerdane, Yassamine, et al.
Publicado: (2022)

Pharmacological Treatment of Tremor in Parkinson’s Disease Revisited
por: Pirker, Walter, et al.
Publicado: (2023)

Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson’s disease
por: Yun, Seung Pil, et al.
Publicado: (2018)

DMSO-tolerant ornithine decarboxylase (ODC) tandem assay optimised for high-throughput screening
por: Park, Mingu Gordon, et al.
Publicado: (2022)

Neuroprotection and Disease Modification by Astrocytes and Microglia in Parkinson Disease
por: Takahashi, Shinichi, et al.
Publicado: (2022)

Astrocytes revisited: concise historic outlook on glutamate homeostasis and signaling
por: Parpura, Vladimir, et al.
Publicado: (2012)

Rest tremor revisited: Parkinson’s disease and other disorders
por: Chen, Wei, et al.
Publicado: (2017)

Treating Parkinson’s disease by astrocyte reprogramming: Progress and challenges
por: Wei, Zhuang-Yao D., et al.
Publicado: (2021)

Targets for astrocyte-based treatments of Parkinson’s disease (PD)
por: Parmar, Malin
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_krfu3klsqgqvvd7g46jo6tfqj3